References
- Shannon R. P., Meade N., Sears M. L. The effect of dopamine on the intraocular pressure and pupil of the rabbit eye. Invest. Ophthalmol. 1976; 15: 371–380
- Macri F. J., Cervario S. J. The inhibitory actions of dopamine, hydroxyamphetamine and phenylephrine on aqueous humor formation. Exp. Eye Res. 1978; 26: 85–98
- Potter D. E., Burke J. A., Chang F. W. Alteration in ocular function induced by phenylethylamine analogs of dopamine. Curr. Eye Res. 1984; 3: 851–859
- Potter D. E., Rowland J. M. Adrenergic drugs and intraocular pressure: effects of selective beta‐adrenergic agonists. Exp. Eye Res. 1978; 27: 615–625
- Chiou G. C.Y., Chiou F. Y. Dopaminergic involvement in intraocular pressure in the rabbit eye. Ophth. Res. 1983; 15: 131–135
- Potter D. E., Burke J. A., Chang F. W. Ocular hypotensive action of ergoline derivatives in rabbits: effect of sympathectomy and domperidone pretreatment. Curr. Eye Res. 1984; 3: 307–314
- Chiou G. C.Y. Ocular hypotensive action of haloperidol, a dopaminergic antagonist. Arch. Ophthalmol. 1984; 102: 143–145
- Chiou G. C.Y. Reduction of intraocular pressure by domperidone. J. Ocular Pharmacol. 1986; 2: 131–138
- Mekki G. A., Turner P. Stimulation of dopamine receptors type 2) lowers human intraocular pressure. Brit. J. Ophthalmol. 1985; 69: 909–910
- Mekki Q. A., Warrington S. J., Turner P. Bromocryptine eyedrops lower intraocular pressure without affecting prolactin levels. Lancet 1984; 1: 287–288
- Chiou G. C.Y. Treatment of ocular hypertension and glaucoma with dopamine antagonists. Ophth. Res. 1984; 16: 129–134
- Sheppard J. D., Schaid D. J. Oral haloperidol lowers human intraocular pressure. J. Ocular Pharmacol. 1986; 2: 215–224
- Goldberg L. I., Kohli J. D., Kotake A. N., Volkman P. H. Characteristics of the dopamine vascular receptor: Comparison with other receptors. Federal Proceed. 1978; 37: 82–88
- Osborne N. N. Binding of 3H‐ADTN, a dopamine agonist, to membranes of the bovine retina. Cell. Mol. Neurobiol. 1981; 1: 167–174
- Bradford M. M. A rapid and sensitive method of guantitation of microgram quantities of protein utilizing the principal of protein‐dye binding. Anal. Biochem. 1976; 72: 248–254
- Cheng Y. C., Prusoff W. H. Relationship between inhibition constant Ki and the concentration which causes 50% inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
- Martres M. P., Sales N., Borthenet M. L., Schwartz J. C. Localization and pharmacological characterization of D‐2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I] iodosulpiride. Eur. J. Pharmacol. 1985; 118: 211–219
- Urwyler S., Markstein R. Identification of dopamine “D3” and “D4” binding sites, labeled with [3H] 2‐amino‐6,7‐dihydroxy‐1,2,3,4‐tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. J. Neurochem. 1986; 46: 1058–1067
- Elena P. P., Denis P., Kosina‐Boix M., Lapalus P. Dopamine receptors in rabbit and rat eye: characterization and localization of DA1 and DA2 binding sites. Curr. Eye Res. 1989; 8: 75–83